A LinkedIn post from AcuityMD highlights the company’s sponsorship of the MassMEDIC MedTech Impact Symposium in Boston, where 50 MedTech experts are set to discuss how to expand access to high-quality care without hindering innovation. The post notes that CEO and co-founder Michael Monovoukas will moderate a panel focused on the future of implantable and biointegrated systems.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, the panel will feature executives from Icotec Medical, Endospan, Smith & Nephew, and Johnson & Johnson, who are expected to address emerging trends, breakthroughs, and clinical successes in MedTech. This involvement suggests AcuityMD is positioning itself closer to leading device manufacturers and strategic decision-makers, which may enhance its visibility in the sector and potentially support future commercial partnerships or product adoption.